Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
2,381,366
Value
$216.1M
% of portfolio
0.4%
Quarters held
22
Since Q1 2021
Holdings of ABT by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,381,366$216.1M0.4%+596,769+33.4%AddedHolders
Q1 20261,784,597$183.2M0.3%−574,542−24.4%ReducedHolders
Q4 20252,359,139$295.6M0.5%−916,838−28.0%ReducedHolders
Q3 20253,275,977$438.8M0.7%−1,702−0.1%ReducedHolders
Q2 20253,277,679$445.8M0.8%+170,122+5.5%AddedHolders
Q1 20253,107,557$412.2M0.8%+79,351+2.6%AddedHolders
Q4 20243,028,206$342.5M0.6%−208,595−6.4%ReducedHolders
Q3 20243,236,801$369.0M0.6%+124,391+4.0%AddedHolders
Q2 20243,112,410$323.4M0.6%+10,278+0.3%AddedHolders
Q1 20243,102,132$352.6M0.6%−323,699−9.4%ReducedHolders
Q4 20233,425,831$377.1M0.7%−629,292−15.5%ReducedHolders
Q3 20234,055,123$392.7M0.8%−175,422−4.1%ReducedHolders
Q2 20234,230,545$461.2M0.9%−102,517−2.4%ReducedHolders
Q1 20234,333,062$438.8M0.9%+312,414+7.8%AddedHolders
Q4 20224,020,648$441.4M1.0%−8,901−0.2%ReducedHolders
Q3 20224,029,549$389.9M1.0%+77,270+2.0%AddedHolders
Q2 20223,952,279$429.4M1.0%+156,071+4.1%AddedHolders
Q1 20223,796,208$449.3M0.9%+240,606+6.8%AddedHolders
Q4 20213,555,602$500.4M1.0%+150,914+4.4%AddedHolders
Q3 20213,404,688$402.2M0.8%−72,839−2.1%ReducedHolders
Q2 20213,477,527$403.1M0.8%−12,717−0.4%ReducedHolders
Q1 20213,490,244$418.3M0.9%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.